The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia
Open accessAbstract
While the dopamine hypothesis has dominated schizophrenia research for several decades, more recent studies have highlighted the role of fast synaptic transmitters and their receptors in schizophrenia etiology. Here we review evidence that schizophrenia is associated with a reduction in N-methyl-D-aspartate receptor (NMDAR) function. By highlighting post mortem, neuroimaging and electrophysiological studies, we provide evidence for preferential disruption of GABAergic circuits in the context of NMDAR hypo-activity states. The functional relationship between NMDARs and GABAergic neurons is realized at the molecular, cellular, microcircuit and systems levels. A synthesis of findings across these levels explains how NMDA-mediated inhibitory dysfunction may lead to aberrant interactions among brain regions, accounting for key clinical features of schizophrenia. This synthesis of schizophrenia unifies observations from diverse fields and may help chart pathways for developing novel diagnostics and therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A default mode of brain function
Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.676 · Cited by 12,190
A synaptic model of memory: long-term potentiation in the hippocampus
Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566
The Glutamate Receptor Ion Channels
Dingledine, R., Borges, K., Bowie, D., & Traynelis, S. F. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01394-2 · Cited by 3,554 · cited 2×
“subunits confer distinct functional properties (Dingledine et al., 1999).”
BackgroundMonyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Mechanisms of Gamma Oscillations
Buzsáki, G., & Wang, X.-J. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150444 · Cited by 2,796
Parvalbumin neurons and gamma rhythms enhance cortical circuit performance
Sohal, V. S., Zhang, F., Yizhar, O., & Deisseroth, K. (2009) · Nature · doi:10.1038/nature07991 · Cited by 2,606
Driving fast-spiking cells induces gamma rhythm and controls sensory responses
Cardin, J. A., Carlén, M., Meletis, K., Knoblich, U., Zhang, F., Deisseroth, K., Tsai, L.-H., & Moore, C. I. (2009) · Nature · doi:10.1038/nature08002 · Cited by 2,603
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
Spontaneous neuronal activity distinguishes human dorsal and ventral attention systems
Fox, M. D., Corbetta, M., Snyder, A. Z., Vincent, J. L., & Raichle, M. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604187103 · Cited by 2,101
Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks
Bartos, M., Vida, I., & Jonas, P. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2044 · Cited by 2,070
Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology
Voineagu, I., Wang, X., Johnston, P., Lowe, J. K., Tian, Y., Horvath, S., Mill, J., Cantor, R. M., Blencowe, B. J., & Geschwind, D. H. (2011) · Nature · doi:10.1038/nature10110 · Cited by 1,874 · cited 2×
“In fact, many proteins involved in these pathways, including the CaV1 channel, calcineurin, CaMKIIβ and CaMKIIγ, and BDNF and its receptor TrkB have all been linked to schizophrenia and related neuropsychiatric disorders such as autism (Gerber et al., 2003; Glausier and Lewis, 2011; Lewis et al., 2011, 2012; Voineagu…”
BackgroundMoghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793 · cited 3×
“2 enhanced excitability of the prefrontal cortex (Moghaddam et al., 1997), first appearing as reduced activity of GABAergic interneurons, followed by increased activity of pyramidal neurons and disruptions in patterns of spontaneous bursts and loss of variability in spike trains (Homayoun et al.”
BackgroundInfluentialExtrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Kynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530
Genome-wide association analysis identifies 13 new risk loci for schizophrenia
Multicenter Genetic Studies of Schizophrenia Consortium, Ripke, S., Psychosis Endophenotypes International Consortium, Wellcome Trust Case Control Consortium 2, O'Dushlaine, C., Chambert, K., Moran, J. L., Kähler, A. K., Akterin, S., Bergen, S. E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2742 · Cited by 1,496
Whitfield-Gabrieli, S., Thermenos, H. W., Milanovic, S., Tsuang, M. T., Faraone, S. V., McCarley, R. W., Shenton, M. E., Green, A. I., Nieto-Castanon, A., LaViolette, P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809141106 · Cited by 1,435
Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231
Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia
Lewis, D. A., Curley, A. A., Glausier, J. R., & Volk, D. W. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.10.004 · Cited by 1,071 · cited 1×
“…the CaV1 channel, calcineurin, CaMKIIβ and CaMKIIγ, and BDNF and its receptor TrkB have all been linked to schizophrenia and related neuropsychiatric disorders such as autism (Gerber et al., 2003; Glausier and Lewis, 2011; Lewis et al., 2011, 2012; Voineagu et al., 2011; Hamshere et al., 2012).”
BackgroundLisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002
Cognitive Recovery in Socially Deprived Young Children: The Bucharest Early Intervention Project
Nelson, C. A., Zeanah, C. H., Fox, N. A., Marshall, P. J., Smyke, A. T., & Guthrie, D. (2007) · Science · doi:10.1126/science.1143921 · Cited by 951 · cited 1×
“T) coupling is essential for developmental plasticity and is thought to be the underlying mechanism for how sensory enrichment can rescue abnormalities stemming from early deprivation (Maurer et al., 1999; Nelson et al., 2007).”
BackgroundHashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06315.2003 · Cited by 938
Long-term depression in the CNS
Collingridge, G. L., Peineau, S., Howland, J. G., & Wang, Y. T. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2867 · Cited by 926
The tripartite synapse: roles for gliotransmission in health and disease
Halassa, M. M., Fellin, T., & Haydon, P. G. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.12.005 · Cited by 852
Self-citationPatterned Activity, Synaptic Convergence, and the NMDA Receptor in Developing Visual Pathways
Constantine-Paton, M., Cline, H. T., & Debski, E. (1990) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.13.030190.001021 · Cited by 784
Parvalbumin-expressing basket-cell network plasticity induced by experience regulates adult learning
Donato, F., Rompani, S. B., & Caroni, P. (2013) · Nature · doi:10.1038/nature12866 · Cited by 703
Perineuronal nets protect fast-spiking interneurons against oxidative stress
Cabungcal, J.-H., Steullet, P., Morishita, H., Kraftsik, R., Cuenod, M., Hensch, T. K., & Do, K. Q. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300454110 · Cited by 512
Hashimoto, T., Arion, D., Unger, T., Maldonado-Avilés, J. G., Morris, H. M., Volk, D. W., Mirnics, K., & Lewis, D. A. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002011 · Cited by 490
Lodge, D. J., Behrens, M. M., & Grace, A. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5419-08.2009 · Cited by 488
Korotkova, T., Fuchs, E. C., Ponomarenko, A., von Engelhardt, J., & Monyer, H. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.017 · Cited by 480 · cited 4×
“…on PV+cells results in the disruption of the gamma rhythm, a physiological phenotype found in schizophrenia patients, and one that correlates with schizophrenia-like symptoms in animals (Lisman et al., 2008; Gonzalez-Burgos et al., 2010; Korotkova et al., 2010; Carlén et al., 2012; Kocsis, 2012).”
BackgroundInfluentialA neoHebbian framework for episodic memory; role of dopamine-dependent late LTP
Lisman, J., Grace, A. A., & Duzel, E. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.07.006 · Cited by 465 · cited 1×
“Abnormal dopamine release remains highly relevant to deficits in reward response, novelty detection, attention and neuroplasticity in schizophrenia (Goto et al., 2010; Lisman et al., 2011).”
BackgroundKapur, S., & Seeman, P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001093 · Cited by 459 · cited 2×
“Ketamine and phencyclidine both have high affinity for D(2) and 5-HT(2) receptors (Kapur and Seeman, 2002), and ketamine binds to allosteric sites on the nicotinic cholinergic receptor complex, which complicates interpretation of studies employing these agents as behavioral models for schizophrenia.”
BackgroundBuchanan, R. W., Javitt, D. C., Marder, S. R., Schooler, N. R., Gold, J. M., McMahon, R. P., Heresco-Levy, U., & Carpenter, W. T. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06081358 · Cited by 419
Regulation of neuronal input transformations by tunable dendritic inhibition
Lovett-Barron, M., Turi, G. F., Kaifosh, P., Lee, P. H., Bolze, F., Sun, X.-H., Nicoud, J.-F., Zemelman, B. V., Sternson, S. M., & Losonczy, A. (2012) · Nature Neuroscience · doi:10.1038/nn.3024 · Cited by 417
Spiegel, I., Mardinly, A. R., Gabel, H. W., Bazinet, J. E., Couch, C. H., Tzeng, C. P., Harmin, D. A., & Greenberg, M. E. (2014) · Cell · doi:10.1016/j.cell.2014.03.058 · Cited by 416 · cited 2×
“, 2011), and development of synapses (Bloodgood et al., 2013; Spiegel et al., 2014).”
BackgroundYoon, J. H., Maddock, R. J., Rokem, A., Silver, M. A., Minzenberg, M. J., Ragland, J. D., & Carter, C. S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6158-09.2010 · Cited by 408 · cited 1×
“In schizophrenia patients, GABA concentration is reduced in visual cortex, an attribute that correlates with aberrant visual sensory processing (Yoon et al., 2010).”
BackgroundCognitive Dysfunction in Schizophrenia: Convergence of γ-Aminobutyric Acid and Glutamate Alterations
Lewis, D. A., & Moghaddam, B. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1372 · Cited by 404 · cited 3×
“The contribution of NMDAR channel currents may be accentuated in inhibitory neurons because their average membrane potential is more depolarized and thus more favorable to removal of pore block by Mg2+ (Lewis and Moghaddam, 2006).”
BackgroundBeasley, C. L., Zhang, Z. J., Patten, I., & Reynolds, G. P. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01360-4 · Cited by 374
Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia
Vacic, V., McCarthy, S., Malhotra, D., Murray, F., Chou, H.-H., Peoples, A., Makarov, V., Yoon, S., Bhandari, A., Corominas, R., et al. (2011) · Nature · doi:10.1038/nature09884 · Cited by 337
Kinney, J. W., Davis, C. N., Tabarean, I., Conti, B., Bartfai, T., & Behrens, M. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4722-05.2006 · Cited by 329 · cited 6×
“In cultured cortical neurons, NMDAR antagonism with ketamine reduces expression of GAD67, a GABA synthesizing enzyme that defines a major population of inhibitory interneurons (Kinney et al., 2006).”
BackgroundResultInfluentialDeletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia
Moreno-De-Luca, D., Mulle, J. G., Kaminsky, E. B., Sanders, S. J., Myers, S. M., Adam, M. P., Pakula, A. T., Eisenhauer, N. J., Uhas, K., Weik, L., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.10.004 · Cited by 324
Pomarol-Clotet, E., Salvador, R., Sarró, S., Gomar, J., Vila, F., Martínez, Á., Guerrero, A., Ortiz-Gil, J., Sans-Sansa, B., Capdevila, A., et al. (2008) · Psychological Medicine · doi:10.1017/s0033291708003565 · Cited by 315
The activity-dependent transcription factor NPAS4 regulates domain-specific inhibition
Bloodgood, B. L., Sharma, N., Browne, H. A., Trepman, A. Z., & Greenberg, M. E. (2013) · Nature · doi:10.1038/nature12743 · Cited by 310
State-dependent architecture of thalamic reticular subnetworks
Halassa, M. M., Chen, Z., Wimmer, R. D., Brunetti, P. M., Zhao, S., Zikopoulos, B., Wang, F., Brown, E. N., & Wilson, M. A. (2014) · Cell · doi:10.1016/j.cell.2014.06.025 · Cited by 309
Self-citationThalamic dysfunction in schizophrenia suggested by whole-night deficits in slow and fast spindles
Ferrarelli, F., Peterson, M. J., Sarasso, S., Riedner, B. A., Murphy, M. J., Benca, R. M., Bria, P., Kalin, N. H., & Tononi, G. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09121731 · Cited by 301 · cited 9×
“NMDARs also regulate expression of parvalbumin (PV) (Kinney et al., 2006), a Ca2+ binding protein that defines a subpopulation of inhibitory neurons andmodulates its firing properties (shown in the thalamic reticular nucleus [TRN]; Albéri et al., 2013) and plasticity (shown in the cerebellum; Caillard et al., 2000).”
InfluentialStone, J. M., Dietrich, C., Edden, R., Mehta, M. A., De Simoni, S., Reed, L. J., Krystal, J. H., Nutt, D., & Barker, G. J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.171 · Cited by 295
Neuronal activity is required for the development of specific cortical interneuron subtypes
De Marco García, N. V., Karayannis, T., & Fishell, G. (2011) · Nature · doi:10.1038/nature09865 · Cited by 294
Krystal, J. H., Abi-Saab, W., Perry, E., D’Souza, D. C., Liu, N., Gueorguieva, R., McDougall, L., Hunsberger, T., Belger, A., Levine, L., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1982-8 · Cited by 272
Mg2+Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine
Kotermanski, S. E., & Johnson, J. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3703-08.2009 · Cited by 271
Attentional modulation of thalamic reticular neurons
McAlonan, K., Cavanaugh, J., & Wurtz, R. H. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5602-05.2006 · Cited by 261
Alterations of cortical GABA neurons and network oscillations in schizophrenia
Gonzalez-Burgos, G., Hashimoto, T., & Lewis, D. A. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0124-8 · Cited by 260
Anticevic, A., Gancsos, M., Murray, J. D., Repovs, G., Driesen, N. R., Ennis, D. J., Niciu, M. J., Morgan, P. T., Surti, T. S., Bloch, M. H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208494109 · Cited by 243
Fellin, T., Halassa, M. M., Terunuma, M., Succol, F., Takano, H., Frank, M., Moss, S. J., & Haydon, P. G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906419106 · Cited by 227
Self-citationDriesen, N. R., McCarthy, G., Bhagwagar, Z., Bloch, M., Calhoun, V, D'Souza, D. C., Gueorguieva, R., He, G., Ramachandran, R., Suckow, R. F., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.194 · Cited by 224 · cited 6×
“Ketamine also increased global measures of functional connectivity in correlation with positive and negative symptoms (Driesen et al., 2013), consistent with resting-state hyperconnectivity in schizophrenia (Chai et al., 2011; Woodward et al., 2011, 2012; Guller et al., 2012).”
BackgroundResultInfluentialMicrodeletions of 3q29 confer high risk for schizophrenia
Mulle, J. G., Dodd, A. F., McGrath, J. A., Wolyniec, P. S., Mitchell, A. A., Shetty, A. C., Sobreira, N. L., Valle, D., Rudd, M. K., Satten, G., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.07.013 · Cited by 223 · cited 2×
“…changes in molecular markers have been observed in other inhibitory interneuron subtypes, including somatostatin (Hashimoto et al., 2008a,2008b; Morris et al., 2008; Beneyto et al., 2012) and VIP (Moreno-De-Luca et al., 2010; Mulle et al., 2010; Levinson et al., 2011; Vacic et al., 2011).”
BackgroundStructural basis for the role of inhibition in facilitating adult brain plasticity
Chen, J. L., Lin, W. C., Cha, J. W., So, P. T., Kubota, Y., & Nedivi, E. (2011) · Nature Neuroscience · doi:10.1038/nn.2799 · Cited by 214
GOFF, D., CATHER, C., GOTTLIEB, J., EVINS, A., WALSH, J., RAEKE, L., OTTO, M., SCHOENFELD, D., & GREEN, M. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.08.012 · Cited by 144 · cited 2×
“, 2005) which has led to intermittent dosing strategies (Goff et al., 2008; Cain et al., 2014).”
BackgroundSelf-citationCircuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia†
Greene, R. (2001) · Hippocampus · doi:10.1002/hipo.1072 · Cited by 140
Bitanihirwe, B., Lim, M., Kelley, J., Kaneko, T., & Woo, T. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-71 · Cited by 137
Yanagi, M., Joho, R. H., Southcott, S. A., Shukla, A. A., Ghose, S., & Tamminga, C. A. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.49 · Cited by 102 · cited 1×
“1 channel which is primarily localized on PV+ interneurons (Yanagi et al., 2014).”
BackgroundPerisomatic inhibition and cortical circuit dysfunction in schizophrenia
Lewis, D. A., Fish, K. N., Arion, D., & Gonzalez-Burgos, G. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.05.013 · Cited by 87
Blot, K., Kimura, S.-I., Bai, J., Kemp, A., Manahan-Vaughan, D., Giros, B., Tzavara, E., & Otani, S. (2015) · Cerebral Cortex · doi:10.1093/cercor/bht329 · Cited by 58
Albéri, L., Lintas, A., Kretz, R., Schwaller, B., & Villa, A. E. P. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00375.2012 · Cited by 49 · cited 1×
“…expression of parvalbumin (PV) (Kinney et al., 2006), a Ca2+ binding protein that defines a subpopulation of inhibitory neurons andmodulates its firing properties (shown in the thalamic reticular nucleus [TRN]; Albéri et al., 2013) and plasticity (shown in the cerebellum; Caillard et al., 2000).”
Background
Research works printed but not linked: 144
- Agim, 2013, Discovery, validation and characterization of Erbb4 and Nrg1 haplotypes using data from three genome-wide association studies of schizophrenia, PLoS ONE, 8, e53042, 10.1371/journal.pone.0053042 · DOI
- Anand, 2000, Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-d-aspartate receptor antagonists, Arch. Gen. Psychiatry, 57, 270, 10.1001/archpsyc.57.3.270 · DOI · Paper page
- Andreassen, 2014, Boosting the power of schizophrenia genetics by leveraging new statistical tools, Schizophr. Bull., 40, 13, 10.1093/schbul/sbt168 · DOI
- Behrens, 2009, Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?, Neuropharmacology, 57, 193, 10.1016/j.neuropharm.2009.06.002 · DOI · Paper page
- Belforte, 2010, Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes, Nat. Neurosci., 13, 76, 10.1038/nn.2447 · DOI · Paper page
- Bellingham, 1998, Developmental changes in EPSC quantal size and quantal content at a central glutamatergic synapse in rat, J. Physiol. Lond., 511, 861, 10.1111/j.1469-7793.1998.861bg.x · DOI
- Benes, 1991, Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients, Arch. Gen. Psychiatry, 48, 996, 10.1001/archpsyc.1991.01810350036005 · DOI · Paper page
- Beneyto, 2008, Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder, Neuropsychopharmacology, 33, 2175, 10.1038/sj.npp.1301604 · DOI · Paper page
- Beneyto, 2012, Lamina- and cell-specific alterations in cortical somatostatin receptor 2 mRNA expression in schizophrenia, Neuropharmacology, 62, 1598, 10.1016/j.neuropharm.2010.12.029 · DOI
- Bird, 1978, Glutamic-acid decarboxylase in schizophrenia, Lancet, 1, 156, 10.1016/S0140-6736(78)90455-5 · doi:10.1016/s0140-6736(78)90455-5
- Bito, 1996, CREB phosphorylation and dephosphorylation: a Ca(2+)- and stimulus duration-dependent switch for hippocampal gene expression, Cell, 87, 1203, 10.1016/S0092-8674(00)81816-4 · DOI · Paper page
- Bourne, 1993, Molecular machines integrate coincident synaptic signals, Cell, 72, 65, 10.1016/S0092-8674(05)80029-7 · DOI · Paper page
- Bradley, 2006, Splice variants of the NR1 subunit differentially induce NMDA receptor-dependent gene expression, J. Neurosci., 26, 1065, 10.1523/JNEUROSCI.3347-05.2006 · DOI
- Caillard, 2000, Role of the calcium-binding protein parvalbumin in short-term synaptic plasticity, Proc. Natl. Acad. Sci. U. S. A., 97, 13372, 10.1073/pnas.230362997 · DOI · Paper page
- Cain, 2014, d-Cycloserine augmentation of cognitive remediation in schizophrenia, Schizophr. Res., 153, 177, 10.1016/j.schres.2014.01.016 · DOI
- Carlén, 2012, A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior, Mol. Psychiatry, 17, 537, 10.1038/mp.2011.31 · DOI · Paper page
- Carlsson, 1990, Schizophrenia: a subcortical neurotransmitter imbalance syndrome?, Schizophr. Bull., 16, 425, 10.1093/schbul/16.3.425 · DOI · Paper page
- Chai, 2011, Abnormal medial prefrontal cortex resting-state connectivity in bipolar disorder and schizophrenia, Neuropsychopharmacology, 36, 2009, 10.1038/npp.2011.88 · DOI · Paper page
- Chattopadhyaya, 2004, Experience and activity-dependent maturation of perisomatic GABAergic innervation in primary visual cortex during a postnatal critical period, J. Neurosci., 24, 9598, 10.1523/JNEUROSCI.1851-04.2004 · DOI · Paper page
- Clementz, 1994, Resting EEG in first-episode schizophrenia patients, bipolar psychosis patients, and their first-degree relatives, Psychophysiology, 31, 486, 10.1111/j.1469-8986.1994.tb01052.x · DOI · Paper page
- Cochran, 2003, Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs, Neuropsychopharmacology, 28, 265, 10.1038/sj.npp.1300031 · DOI · Paper page
- Cohen, 2008, Communication between the synapse and the nucleus in neuronal development, plasticity, and disease, Annu. Rev. Cell Dev. Biol., 24, 183, 10.1146/annurev.cellbio.24.110707.175235 · DOI · Paper page
- Cohen, 1992, Context, cortex, and dopamine: a connectionist approach to behavior and biology in schizophrenia, Psychol. Rev., 99, 45, 10.1037/0033-295X.99.1.45 · DOI · Paper page
- Collingridge, 1988, Synaptic activation of N-methyl-d-aspartate receptors in the Schaffer collateral–commissural pathway of rat hippocampus, J. Physiol. Lond., 399, 283, 10.1113/jphysiol.1988.sp017080 · DOI · Paper page
- Costa, 1990, An open trial of glycine as an adjunct to neuroleptics in chronic treatment-refractory schizophrenics, J. Clin. Psychopharmacol., 10, 71, 10.1097/00004714-199002000-00027 · DOI
- Creese, 1976, Dopamine receptors and average clinical doses, Science, 194, 546, 10.1126/science.194.4264.546 · DOI
- Cui, 2013, Increased NR2A:NR2B ratio compresses long-term depression range and constrains long-term memory, Sci. Rep., 3, 1036, 10.1038/srep01036 · DOI
- Dandash, 2014, Selective augmentation of striatal functional connectivity following NMDA receptor antagonism: implications for psychosis, Neuropsychopharmacology
- Davis, 1991, Dopamine in schizophrenia: a review and reconceptualization, Am. J. Psychiatry, 148, 1474, 10.1176/ajp.148.11.1474 · DOI · Paper page
- Deisseroth, 1998, Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons, Nature, 392, 198, 10.1038/32448 · DOI · Paper page
- Deutsch, 1989, A “glutamatergic hypothesis” of schizophrenia. Rationale for pharmacotherapy with glycine, Clin. Neuropharmacol., 12, 1, 10.1097/00002826-198902000-00001 · DOI · Paper page
- Faber, 1980, Single-shot channel activation accounts for duration of inhibitory postsynaptic potentials in a central neuron, Science, 208, 612, 10.1126/science.6245449 · DOI
- Ferrarelli, 2007, Reduced sleep spindle activity in schizophrenia patients, Am. J. Psychiatry, 164, 483, 10.1176/ajp.2007.164.3.483 · DOI · Paper page
- Filmer, 2014, Applications of transcranial direct current stimulation for understanding brain function, Trends Neurosci., 37, 742, 10.1016/j.tins.2014.08.003 · DOI · Paper page
- Fingelkurts, 2004, Enhancement of GABA-related signalling is associated with increase of functional connectivity in human cortex, Hum. Brain Mapp., 22, 27, 10.1002/hbm.20014 · DOI
- Flint, 1997, NR2A subunit expression shortens NMDA receptor synaptic currents in developing neocortex, J. Neurosci., 17, 2469, 10.1523/JNEUROSCI.17-07-02469.1997 · DOI · Paper page
- Fumagalli, 2008, Dynamic regulation of glutamatergic postsynaptic activity in rat prefrontal cortex by repeated administration of antipsychotic drugs, Mol. Pharmacol., 73, 1484, 10.1124/mol.107.043786 · DOI
- Garrity, 2007, Aberrant “default mode” functional connectivity in schizophrenia, Am. J. Psychiatry, 164, 450, 10.1176/ajp.2007.164.3.450 · DOI · Paper page
- Georgiev, 2014, Lower gene expression for KCNS3 potassium channel subunit in parvalbumin-containing neurons in the prefrontal cortex in schizophrenia, Am. J. Psychiatry, 171, 62, 10.1176/appi.ajp.2013.13040468 · DOI · Paper page
- Gerber, 2003, Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit, Proc. Natl. Acad. Sci. U. S. A., 100, 8993, 10.1073/pnas.1432927100 · DOI · Paper page
- Gilani, 2014, Interneuron precursor transplants in adult hippocampus reverse psychosis-relevant features in a mouse model of hippocampal disinhibition, Proc. Natl. Acad. Sci. U. S. A., 111, 7450, 10.1073/pnas.1316488111 · DOI
- Glausier, 2011, Selective pyramidal cell reduction of GABA(A) receptor a1 subunit messenger RNA expression in schizophrenia, Neuropsychopharmacology, 36, 2103, 10.1038/npp.2011.102 · DOI
- Goff, 2014, Bitopertin: the good news and bad news, JAMA Psychiatry, 71, 621, 10.1001/jamapsychiatry.2014.257 · DOI
- Goff, 1999, A placebo-controlled crossover trial of d-cycloserine added to clozapine in patients with schizophrenia, Biol. Psychiatry, 45, 512, 10.1016/S0006-3223(98)00367-9 · DOI · Paper page
- Goff, 1999, A placebo-controlled trial of d-cycloserine added to conventional neuroleptics in patients with schizophrenia, Arch. Gen. Psychiatry, 56, 21, 10.1001/archpsyc.56.1.21 · DOI · Paper page
- Goff, 2002, Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine, Biol. Psychiatry, 51, 493, 10.1016/S0006-3223(01)01321-X · DOI
- Goff, 2005, A six-month, placebo-controlled trial of d-cycloserine co-administered with conventional antipsychotics in schizophrenia patients, Psychopharmacology (Berlin), 179, 144, 10.1007/s00213-004-2032-2 · DOI
- Goto, 2010, Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders, Biol. Psychiatry, 67, 199, 10.1016/j.biopsych.2009.08.026 · DOI · Paper page
- Gottschalk, 1999, Signaling mechanisms mediating BDNF modulation of synaptic plasticity in the hippocampus, Learn. Mem., 6, 243, 10.1101/lm.6.3.243 · DOI · Paper page
- Götz, 1997, Functional properties of AMPA and NMDA receptors expressed in identified types of basal ganglia neurons, J. Neurosci., 17, 204, 10.1523/JNEUROSCI.17-01-00204.1997 · DOI · Paper page
- Grienberger, 2014, NMDA receptor-dependent multidendrite Ca(2+) spikes required for hippocampal burst firing in vivo, Neuron, 81, 1274, 10.1016/j.neuron.2014.01.014 · DOI · Paper page
- Guller, 2012, Probing thalamic integrity in schizophrenia using concurrent transcranial magnetic stimulation and functional magnetic resonance imaging, Arch. Gen. Psychiatry, 69, 662, 10.1001/archgenpsychiatry.2012.23 · DOI
- Hahn, 2006, Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia, Nat. Med., 12, 824, 10.1038/nm1418 · DOI · Paper page
- Halassa, 2011, Selective optical drive of thalamic reticular nucleus generates thalamic bursts and cortical spindles, Nat. Neurosci., 14, 1118, 10.1038/nn.2880 · DOI · Paper page
- Hallak, 2013, Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial, JAMA Psychiatry, 70, 668, 10.1001/jamapsychiatry.2013.1292 · DOI
- Hamilton, 2013, Optogenetic activation of an inhibitory network enhances feedforward functional connectivity in auditory cortex, Neuron, 80, 1066, 10.1016/j.neuron.2013.08.017 · DOI
- Hamshere, 2012, Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC, Mol. Psychiatry, 18, 708, 10.1038/mp.2012.67 · DOI · Paper page
- Hardingham, 2001, A calcium microdomain near NMDA receptors: on switch for ERK-dependent synapse-to-nucleus communication, Nat. Neurosci., 4, 565, 10.1038/88380 · DOI · Paper page
- Hashimoto, 2008, Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia, Am. J. Psychiatry, 165, 479, 10.1176/appi.ajp.2007.07081223 · DOI · Paper page
- Heresco-Levy, 1999, Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia, Arch. Gen. Psychiatry, 56, 29, 10.1001/archpsyc.56.1.29 · DOI · Paper page
- Heresco-Levy, 2005, d-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia, Biol. Psychiatry, 57, 577, 10.1016/j.biopsych.2004.12.037 · DOI · Paper page
- Holcomb, 2001, Sequential regional cerebral blood flow brain scans using PET with H2(15)O demonstrate ketamine actions in CNS dynamically, Neuropsychopharmacology, 25, 165, 10.1016/S0893-133X(01)00229-9 · DOI
- Homayoun, 2005, Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats, J. Neurophysiol., 93, 1989, 10.1152/jn.00875.2004 · DOI
- Hong, 2008, A biological function for the neuronal activity-dependent component of Bdnf transcription in the development of cortical inhibition, Neuron, 60, 610, 10.1016/j.neuron.2008.09.024 · DOI · Paper page
- Howes, 2012, The nature of dopamine dysfunction in schizophrenia and what this means for treatment, Arch. Gen. Psychiatry, 69, 776, 10.1001/archgenpsychiatry.2012.169 · DOI · Paper page
- Impey, 1998, Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation, Neuron, 21, 869, 10.1016/S0896-6273(00)80602-9 · DOI · Paper page
- Itami, 2007, Brain-derived neurotrophic factor regulates the maturation of layer 4 fast-spiking cells after the second postnatal week in the developing barrel cortex, J. Neurosci., 27, 2241, 10.1523/JNEUROSCI.3345-06.2007 · DOI
- Jackson, 2004, NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex, Proc. Natl. Acad. Sci. U. S. A., 101, 8467, 10.1073/pnas.0308455101 · DOI · Paper page
- Javitt, 1994, Amelioration of negative symptoms in schizophrenia by glycine, Am. J. Psychiatry, 151, 1234, 10.1176/ajp.151.8.1234 · DOI · Paper page
- Kantrowitz, 2010, High dose d-serine in the treatment of schizophrenia, Schizophr. Res., 121, 125, 10.1016/j.schres.2010.05.012 · DOI · Paper page
- Kegeles, 2000, Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia, Biol. Psychiatry, 48, 627, 10.1016/S0006-3223(00)00976-8 · DOI · Paper page
- Klausberger, 2008, Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations, Science, 321, 53, 10.1126/science.1149381 · DOI · Paper page
- Knable, 2002, Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers, Mol. Psychiatry, 7, 392, 10.1038/sj.mp.4001034 · DOI
- Kocsis, 2012, Differential role of NR2A and NR2B subunits in N-methyl-d-aspartate receptor antagonist-induced aberrant cortical gamma oscillations, Biol. Psychiatry, 71, 987, 10.1016/j.biopsych.2011.10.002 · DOI · Paper page
- Krystal, 1999, Interactive effects of subanesthetic ketamine and haloperidol in healthy humans, Psychopharmacology (Berlin), 145, 193, 10.1007/s002130051049 · DOI · Paper page
- Lahti, 1995, Subanesthetic doses of ketamine stimulate psychosis in schizophrenia, Neuropsychopharmacology, 13, 9, 10.1016/0893-133X(94)00131-I · DOI · Paper page
- Levinson, 2011, Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications, Am. J. Psychiatry, 168, 302, 10.1176/appi.ajp.2010.10060876 · DOI · Paper page
- Li, 2002, NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: a potential mechanism of neurotoxicity, J. Neurosci., 22, 3070, 10.1523/JNEUROSCI.22-08-03070.2002 · DOI
- Liu, 2007, More evidence supports the association of PPP3CC with schizophrenia, Mol. Psychiatry, 12, 966, 10.1038/sj.mp.4001977 · DOI
- Liu, 2013, Activation of extrasynaptic NMDA receptors induces LTD in rat hippocampal CA1 neurons, Brain Res. Bull., 93, 10, 10.1016/j.brainresbull.2012.12.003 · DOI
- Luby, 1959, Study of a new schizophrenomimetic drug; sernyl, AMA Arch. Neurol. Psychiatr., 81, 363, 10.1001/archneurpsyc.1959.02340150095011 · DOI · Paper page
- Ma, 2014, γCaMKII shuttles Ca(2+)/CaM to the nucleus to trigger CREB phosphorylation and gene expression, Cell, 159, 281, 10.1016/j.cell.2014.09.019 · DOI · Paper page
- Maurer, 1999, Rapid improvement in the acuity of infants after visual input, Science, 286, 108, 10.1126/science.286.5437.108 · DOI · Paper page
- McAlonan, 2008, Guarding the gateway to cortex with attention in visual thalamus, Nature, 456, 391, 10.1038/nature07382 · DOI · Paper page
- Meador-Woodruff, 2003, Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia, Ann. N. Y. Acad. Sci., 1003, 75, 10.1196/annals.1300.005 · DOI
- Meltzer, 1976, The dopamine hypothesis of schizophrenia: a review, Schizophr. Bull., 2, 19, 10.1093/schbul/2.1.19 · DOI · Paper page
- Miyakawa, 2003, Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia, Proc. Natl. Acad. Sci. U. S. A., 100, 8987, 10.1073/pnas.1432926100 · DOI · Paper page
- Moore, 2010, Neocortical interneurons: from diversity, strength, Cell, 142, 189, 10.1016/j.cell.2010.07.005 · DOI
- Moreau, 2013, NMDA receptor-dependent function and plasticity in inhibitory circuits, Neuropharmacology, 74, 23, 10.1016/j.neuropharm.2013.03.004 · DOI
- Morris, 2008, Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder, Cereb. Cortex, 18, 1575, 10.1093/cercor/bhm186 · DOI · Paper page
- Mothet, 2000, d-serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor, Proc. Natl. Acad. Sci. U. S. A., 97, 4926, 10.1073/pnas.97.9.4926 · DOI · Paper page
- Nong, 2003, Glycine binding primes NMDA receptor internalization, Nature, 422, 302, 10.1038/nature01497 · DOI · Paper page
- Novak, 2000, Schizophrenia: elevated mRNA for calcium–calmodulin-dependent protein kinase IIbeta in frontal cortex, Brain Res. Mol. Brain Res., 82, 95, 10.1016/S0169-328X(00)00188-1 · DOI
- Panatier, 2006, Glia-derived d-serine controls NMDA receptor activity and synaptic memory, Cell, 125, 775, 10.1016/j.cell.2006.02.051 · DOI · Paper page
- Pantazopoulos, 2010, Extracellular matrix–glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia, Arch. Gen. Psychiatry, 67, 155, 10.1001/archgenpsychiatry.2009.196 · DOI · Paper page
- Parnas, 2005, Effects of multiple exposures to d-cycloserine on extinction of conditioned fear in rats, Neurobiol. Learn. Mem., 83, 224, 10.1016/j.nlm.2005.01.001 · DOI
- Patz, 2003, Neuronal activity and neurotrophic factors regulate GAD-65/67 mRNA and protein expression in organotypic cultures of rat visual cortex, Eur. J. Neurosci., 18, 1, 10.1046/j.1460-9568.2003.02702.x · DOI
- Patz, 2004, Parvalbumin expression in visual cortical interneurons depends on neuronal activity and TrkB ligands during an early period of postnatal development, Cereb. Cortex, 14, 342, 10.1093/cercor/bhg132 · DOI · Paper page
- Perouansky, 1993, Kinetic properties of NMDA receptor-mediated synaptic currents in rat hippocampal pyramidal cells versus interneurones, J. Physiol. Lond., 465, 223, 10.1113/jphysiol.1993.sp019674 · DOI
- Piña-Crespo, 2010, Excitatory glycine responses of CNS myelin mediated by NR1/NR3 “NMDA” receptor subunits, J. Neurosci., 30, 11501, 10.1523/JNEUROSCI.1593-10.2010 · DOI
- Potter, 2010, Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior, Neuropsychopharmacology, 35, 1734, 10.1038/npp.2010.39 · DOI · Paper page
- Reif, 2006, A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function, Mol. Psychiatry, 11, 286, 10.1038/sj.mp.4001779 · DOI · Paper page
- Rosse, 1989, Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot study, Clin. Neuropharmacol., 12, 416, 10.1097/00002826-198910000-00006 · DOI
- Rumbaugh, 1999, Distinct synaptic and extrasynaptic NMDA receptors in developing cerebellar granule neurons, J. Neurosci., 19, 10603, 10.1523/JNEUROSCI.19-24-10603.1999 · DOI · Paper page
- Saalmann, 2014, Intralaminar and medial thalamic influence on cortical synchrony, information transmission and cognition, Front. Syst. Neurosci., 9, 83
- Saalmann, 2012, The pulvinar regulates information transmission between cortical areas based on attention demands, Science, 337, 753, 10.1126/science.1223082 · DOI · Paper page
- Schwieler, 2008, Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area, Life Sci., 83, 170, 10.1016/j.lfs.2008.05.014 · DOI
- Sheng, 1991, CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases, Science, 252, 1427, 10.1126/science.1646483 · DOI · Paper page
- Snyder, 1981, Dopamine receptors, neuroleptics, and schizophrenia, Am. J. Psychiatry, 138, 460, 10.1176/ajp.138.4.460 · DOI · Paper page
- Spellman, 2014, Synchrony in schizophrenia: a window into circuit-level pathophysiology, Curr. Opin. Neurobiol., 30C, 17
- Stagg, 2014, Local GABA concentration is related to network-level resting functional connectivity, Elife, 3, e01465, 10.7554/eLife.01465 · DOI · Paper page
- Standaert, 1996, Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus, Brain Res. Mol. Brain Res., 42, 89, 10.1016/S0169-328X(96)00117-9 · DOI · Paper page
- Stefansson, 2002, Neuregulin 1 and susceptibility to schizophrenia, Am. J. Hum. Genet., 71, 877, 10.1086/342734 · DOI · Paper page
- Stocca, 1998, Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons, J. Physiol. Lond., 507, 13, 10.1111/j.1469-7793.1998.013bu.x · DOI · Paper page
- Tong, 1996, Antagonism of NMDA receptors but not AMPA/kainate receptors blocks bursting in dopaminergic neurons induced by electrical stimulation of the prefrontal cortex, J. Neural Transm., 103, 889, 10.1007/BF01291780 · DOI
- Tsai, 1998, d-serine added to antipsychotics for the treatment of schizophrenia, Biol. Psychiatry, 44, 1081, 10.1016/S0006-3223(98)00279-0 · DOI · Paper page
- Tsai, 2004, Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia, Biol. Psychiatry, 55, 452, 10.1016/j.biopsych.2003.09.012 · DOI · Paper page
- Tuominen, 2005, Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis, Schizophr. Res., 72, 225, 10.1016/j.schres.2004.05.005 · DOI · Paper page
- Umbricht, 2014, Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study, JAMA Psychiatry, 71, 637, 10.1001/jamapsychiatry.2014.163 · DOI · Paper page
- Volk, 2000, Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia, Arch. Gen. Psychiatry, 57, 237, 10.1001/archpsyc.57.3.237 · DOI · Paper page
- Vollenweider, 1997, Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18 F]fluorodeoxyglucose (FDG), Eur. Neuropsychopharmacol., 7, 9, 10.1016/S0924-977X(96)00039-9 · DOI · Paper page
- Vullhorst, 2009, Selective expression of ErbB4 in interneurons, but not pyramidal cells, of the rodent hippocampus, J. Neurosci., 29, 12255, 10.1523/JNEUROSCI.2454-09.2009 · DOI · Paper page
- Weickert, 2013, Molecular evidence of N-methyl-d-aspartate receptor hypofunction in schizophrenia, Mol. Psychiatry, 18, 1185, 10.1038/mp.2012.137 · DOI · Paper page
- Weinberger, 1986, Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence, Arch. Gen. Psychiatry, 43, 114, 10.1001/archpsyc.1986.01800020020004 · DOI · Paper page
- Weiser, 2012, A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia, J. Clin. Psychiatry, 73, e728, 10.4088/JCP.11m07031 · DOI
- Wenzel, 1996, Developmental and regional expression of NMDA receptor subtypes containing the NR2D subunit in rat brain, J. Neurochem., 66, 1240, 10.1046/j.1471-4159.1996.66031240.x · DOI
- West, 2002, Regulation of transcription factors by neuronal activity, Nat. Rev. Neurosci., 3, 921, 10.1038/nrn987 · DOI · Paper page
- Wheeler, 2008, CaMKII locally encodes L-type channel activity to signal to nuclear CREB in excitation–transcription coupling, J. Cell Biol., 183, 849, 10.1083/jcb.200805048 · DOI · Paper page
- Wheeler, 2012, Ca(V)1 and Ca(V)2 channels engage distinct modes of Ca(2+) signaling to control CREB-dependent gene expression, Cell, 149, 1112, 10.1016/j.cell.2012.03.041 · DOI · Paper page
- Wiescholleck, 2013, Long-lasting changes in hippocampal synaptic plasticity and cognition in an animal model of NMDA receptor dysfunction in psychosis, Neuropharmacology, 74, 48, 10.1016/j.neuropharm.2013.01.001 · DOI
- Wittmann, 2005, Clozapine potentiation of N-methyl-d-aspartate receptor currents in the nucleus accumbens: role of NR2B and protein kinase A/Src kinases, J. Pharmacol. Exp. Ther., 313, 594, 10.1124/jpet.104.080200 · DOI
- Wobrock, 2007, Cortical excitability in schizophrenia. Studies using transcranial magnetic stimulation, Nervenarzt, 78, 756
- Wolosker, 1999, Serine racemase: a glial enzyme synthesizing d-serine to regulate glutamate–N-methyl-d-aspartate neurotransmission, Proc. Natl. Acad. Sci. U. S. A., 96, 13409, 10.1073/pnas.96.23.13409 · DOI · Paper page
- Woo, 1997, Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons, Am. J. Psychiatry, 154, 1013, 10.1176/ajp.154.7.1013 · DOI · Paper page
- Woo, 2004, Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-d-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder, Arch. Gen. Psychiatry, 61, 649, 10.1001/archpsyc.61.7.649 · DOI · Paper page
- Woodward, 2011, Functional resting-state networks are differentially affected in schizophrenia, Schizophr. Res., 130, 86, 10.1016/j.schres.2011.03.010 · DOI · Paper page
- Woodward, 2012, Thalamocortical dysconnectivity in schizophrenia, Am. J. Psychiatry, 169, 1092, 10.1176/appi.ajp.2012.12010056 · DOI · Paper page
- Wu, 2001, Activity-dependent CREB phosphorylation: convergence of a fast, sensitive calmodulin kinase pathway and a slow, less sensitive mitogen-activated protein kinase pathway, Proc. Natl. Acad. Sci. U. S. A., 98, 2808, 10.1073/pnas.051634198 · DOI · Paper page
- Xi, 2009, NMDA receptor subunit expression in GABAergic interneurons in the prefrontal cortex: application of laser microdissection technique, J. Neurosci. Methods, 176, 172, 10.1016/j.jneumeth.2008.09.013 · DOI
- Yang, 2003, Association study of neuregulin 1 gene with schizophrenia, Mol. Psychiatry, 8, 706, 10.1038/sj.mp.4001377 · DOI · Paper page
- Zhang, 2002, c-fos regulates neuronal excitability and survival, Nat. Genet., 30, 416, 10.1038/ng859 · DOI · Paper page
- Zhang, 2008, Prolonged exposure to NMDAR antagonist suppresses inhibitory synaptic transmission in prefrontal cortex, J. Neurophysiol., 100, 959, 10.1152/jn.00079.2008 · DOI · Paper page
- Zhang, 2009, Inhibition of NMDARs in the nucleus reticularis of the thalamus produces delta frequency bursting, Front Neural Circ., 3, 20
- Zhang, 2012, NR2C in the thalamic reticular nucleus; effects of the NR2C knockout, PLoS ONE, 7, e41908, 10.1371/journal.pone.0041908 · DOI
Cited by
Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
McCutcheon, R. A., Krystal, J. H., & Howes, O. D. (2020) · World Psychiatry · doi:10.1002/wps.20693 · Cited by 612
Gut microbiota and the neuroendocrine system
Farzi, A., Fröhlich, E. E., & Holzer, P. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0600-5 · Cited by 478
Behl, T., Kaur, D., Sehgal, A., Singh, S., Sharma, N., Zengin, G., Andronie-Cioara, F. L., Toma, M. M., Bungau, S., & Bumbu, A. G. (2021) · Molecules · doi:10.3390/molecules26123724 · Cited by 317
Yan, Z., & Rein, B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01092-3 · Cited by 300
“Postmortem schizophrenia studies have revealed supporting evidence [171], including the reduced density of NR2A-expressing PV interneurons in cortical layers 3 and 4 [172] and the reduced density of GAD67-and NR2A-coexpressing neurons in layers 2 and 5 of the anterior cingulate cortex [173].”
BackgroundThe origin of NMDA receptor hypofunction in schizophrenia
Nakazawa, K., & Sapkota, K. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107426 · Cited by 275
Metadata
- Authors
- Cohen, S. M., Tsien, R. W., Goff, D. C., & Halassa, M. M.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 167
- Issue
- 1-3
- Pages
- 98-107
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2006955019
- Cited by
- 232
- References
- 66
- FWCI
- 18.33
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.